Llwytho...
CD46 and Oncologic Interactions: Friendly Fire against Cancer
One of the most challenging aspects of cancer therapeutics is target selection. Recently, CD46 (membrane cofactor protein; MCP) has emerged as a key player in both malignant transformation as well as in cancer treatments. Normally a regulator of complement activation, CD46 is co-expressed as four pr...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Antibodies (Basel) |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
MDPI
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7709105/ https://ncbi.nlm.nih.gov/pubmed/33147799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antib9040059 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|